Molecular Diversity in Drug Design:
High-throughput screening and combinatorial chemistry are two of the most potent weapons ever to have been used in the discovery of new drugs. At a stroke, it seems to be possible to synthesise more molecules in a month than have previously been made in the whole of the distinguished history of orga...
Gespeichert in:
Weitere Verfasser: | , |
---|---|
Format: | Elektronisch E-Book |
Sprache: | English |
Veröffentlicht: |
Dordrecht
Springer Netherlands
2002
|
Schlagworte: | |
Online-Zugang: | UBT01 URL des Erstveröffentlichers |
Zusammenfassung: | High-throughput screening and combinatorial chemistry are two of the most potent weapons ever to have been used in the discovery of new drugs. At a stroke, it seems to be possible to synthesise more molecules in a month than have previously been made in the whole of the distinguished history of organic chemistry, Furthermore, all the molecules can be screened in the same short period. However, like any weapons of immense power, these techniques must be used with care, to achieve maximum impact. The costs of implementing and running high-throughput screening and combinatorial chemistry are high, as large dedicated facilities must be built and staffed. In addition, the sheer number of chemical leads generated may overwhelm the lead optimisation teams in a hail of friendly fire. Mother nature has not entirely surrendered, as the number of building blocks that could be used to build libraries would require more atoms than there are in the universe. In addition, the progress made by the Human Genome Project has uncovered many proteins with different functions but related binding sites, creating issues of selectivity. Advances in the new field of pharmacogenomics will produce more of these challenges. There is a real need to make hi- throughput screening and combinatorial chemistry into 'smart' weapons, so that their power is not dissipated. That is the challenge for modellers, computational chemists, cheminformaticians and IT experts. In this book, we have broken down this grand challenge into key tasks |
Beschreibung: | 1 Online-Ressource (XIV, 254 p) |
ISBN: | 9780306468735 |
DOI: | 10.1007/0-306-46873-5 |
Internformat
MARC
LEADER | 00000nmm a2200000zc 4500 | ||
---|---|---|---|
001 | BV045151653 | ||
003 | DE-604 | ||
005 | 00000000000000.0 | ||
007 | cr|uuu---uuuuu | ||
008 | 180828s2002 |||| o||u| ||||||eng d | ||
020 | |a 9780306468735 |9 978-0-306-46873-5 | ||
024 | 7 | |a 10.1007/0-306-46873-5 |2 doi | |
035 | |a (ZDB-2-CMS)978-0-306-46873-5 | ||
035 | |a (OCoLC)1050946903 | ||
035 | |a (DE-599)BVBBV045151653 | ||
040 | |a DE-604 |b ger |e aacr | ||
041 | 0 | |a eng | |
049 | |a DE-703 | ||
082 | 0 | |a 541.0285 |2 23 | |
245 | 1 | 0 | |a Molecular Diversity in Drug Design |c edited by Philip M. Dean, Richard A. Lewis |
264 | 1 | |a Dordrecht |b Springer Netherlands |c 2002 | |
300 | |a 1 Online-Ressource (XIV, 254 p) | ||
336 | |b txt |2 rdacontent | ||
337 | |b c |2 rdamedia | ||
338 | |b cr |2 rdacarrier | ||
520 | |a High-throughput screening and combinatorial chemistry are two of the most potent weapons ever to have been used in the discovery of new drugs. At a stroke, it seems to be possible to synthesise more molecules in a month than have previously been made in the whole of the distinguished history of organic chemistry, Furthermore, all the molecules can be screened in the same short period. However, like any weapons of immense power, these techniques must be used with care, to achieve maximum impact. The costs of implementing and running high-throughput screening and combinatorial chemistry are high, as large dedicated facilities must be built and staffed. In addition, the sheer number of chemical leads generated may overwhelm the lead optimisation teams in a hail of friendly fire. Mother nature has not entirely surrendered, as the number of building blocks that could be used to build libraries would require more atoms than there are in the universe. In addition, the progress made by the Human Genome Project has uncovered many proteins with different functions but related binding sites, creating issues of selectivity. Advances in the new field of pharmacogenomics will produce more of these challenges. There is a real need to make hi- throughput screening and combinatorial chemistry into 'smart' weapons, so that their power is not dissipated. That is the challenge for modellers, computational chemists, cheminformaticians and IT experts. In this book, we have broken down this grand challenge into key tasks | ||
650 | 4 | |a Chemistry | |
650 | 4 | |a Computer Applications in Chemistry | |
650 | 4 | |a Pharmacy | |
650 | 4 | |a Theoretical and Computational Chemistry | |
650 | 4 | |a Chemistry | |
650 | 4 | |a Pharmacy | |
650 | 4 | |a Chemoinformatics | |
650 | 4 | |a Chemistry, Physical and theoretical | |
700 | 1 | |a Dean, Philip M. |4 edt | |
700 | 1 | |a Lewis, Richard A. |4 edt | |
776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9780792359807 |
856 | 4 | 0 | |u https://doi.org/10.1007/0-306-46873-5 |x Verlag |z URL des Erstveröffentlichers |3 Volltext |
912 | |a ZDB-2-CMS | ||
940 | 1 | |q ZDB-2-CMS_2000/2004 | |
999 | |a oai:aleph.bib-bvb.de:BVB01-030541321 | ||
966 | e | |u https://doi.org/10.1007/0-306-46873-5 |l UBT01 |p ZDB-2-CMS |q ZDB-2-CMS_2000/2004 |x Verlag |3 Volltext |
Datensatz im Suchindex
_version_ | 1804178823890075648 |
---|---|
any_adam_object | |
author2 | Dean, Philip M. Lewis, Richard A. |
author2_role | edt edt |
author2_variant | p m d pm pmd r a l ra ral |
author_facet | Dean, Philip M. Lewis, Richard A. |
building | Verbundindex |
bvnumber | BV045151653 |
collection | ZDB-2-CMS |
ctrlnum | (ZDB-2-CMS)978-0-306-46873-5 (OCoLC)1050946903 (DE-599)BVBBV045151653 |
dewey-full | 541.0285 |
dewey-hundreds | 500 - Natural sciences and mathematics |
dewey-ones | 541 - Physical chemistry |
dewey-raw | 541.0285 |
dewey-search | 541.0285 |
dewey-sort | 3541.0285 |
dewey-tens | 540 - Chemistry and allied sciences |
discipline | Chemie / Pharmazie |
doi_str_mv | 10.1007/0-306-46873-5 |
format | Electronic eBook |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03086nmm a2200469zc 4500</leader><controlfield tag="001">BV045151653</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">180828s2002 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780306468735</subfield><subfield code="9">978-0-306-46873-5</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/0-306-46873-5</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-2-CMS)978-0-306-46873-5</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1050946903</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV045151653</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-703</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">541.0285</subfield><subfield code="2">23</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Molecular Diversity in Drug Design</subfield><subfield code="c">edited by Philip M. Dean, Richard A. Lewis</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Dordrecht</subfield><subfield code="b">Springer Netherlands</subfield><subfield code="c">2002</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (XIV, 254 p)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">High-throughput screening and combinatorial chemistry are two of the most potent weapons ever to have been used in the discovery of new drugs. At a stroke, it seems to be possible to synthesise more molecules in a month than have previously been made in the whole of the distinguished history of organic chemistry, Furthermore, all the molecules can be screened in the same short period. However, like any weapons of immense power, these techniques must be used with care, to achieve maximum impact. The costs of implementing and running high-throughput screening and combinatorial chemistry are high, as large dedicated facilities must be built and staffed. In addition, the sheer number of chemical leads generated may overwhelm the lead optimisation teams in a hail of friendly fire. Mother nature has not entirely surrendered, as the number of building blocks that could be used to build libraries would require more atoms than there are in the universe. In addition, the progress made by the Human Genome Project has uncovered many proteins with different functions but related binding sites, creating issues of selectivity. Advances in the new field of pharmacogenomics will produce more of these challenges. There is a real need to make hi- throughput screening and combinatorial chemistry into 'smart' weapons, so that their power is not dissipated. That is the challenge for modellers, computational chemists, cheminformaticians and IT experts. In this book, we have broken down this grand challenge into key tasks</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Chemistry</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Computer Applications in Chemistry</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmacy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Theoretical and Computational Chemistry</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Chemistry</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmacy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Chemoinformatics</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Chemistry, Physical and theoretical</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Dean, Philip M.</subfield><subfield code="4">edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lewis, Richard A.</subfield><subfield code="4">edt</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9780792359807</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1007/0-306-46873-5</subfield><subfield code="x">Verlag</subfield><subfield code="z">URL des Erstveröffentlichers</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-2-CMS</subfield></datafield><datafield tag="940" ind1="1" ind2=" "><subfield code="q">ZDB-2-CMS_2000/2004</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-030541321</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1007/0-306-46873-5</subfield><subfield code="l">UBT01</subfield><subfield code="p">ZDB-2-CMS</subfield><subfield code="q">ZDB-2-CMS_2000/2004</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
id | DE-604.BV045151653 |
illustrated | Not Illustrated |
indexdate | 2024-07-10T08:10:06Z |
institution | BVB |
isbn | 9780306468735 |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-030541321 |
oclc_num | 1050946903 |
open_access_boolean | |
owner | DE-703 |
owner_facet | DE-703 |
physical | 1 Online-Ressource (XIV, 254 p) |
psigel | ZDB-2-CMS ZDB-2-CMS_2000/2004 ZDB-2-CMS ZDB-2-CMS_2000/2004 |
publishDate | 2002 |
publishDateSearch | 2002 |
publishDateSort | 2002 |
publisher | Springer Netherlands |
record_format | marc |
spelling | Molecular Diversity in Drug Design edited by Philip M. Dean, Richard A. Lewis Dordrecht Springer Netherlands 2002 1 Online-Ressource (XIV, 254 p) txt rdacontent c rdamedia cr rdacarrier High-throughput screening and combinatorial chemistry are two of the most potent weapons ever to have been used in the discovery of new drugs. At a stroke, it seems to be possible to synthesise more molecules in a month than have previously been made in the whole of the distinguished history of organic chemistry, Furthermore, all the molecules can be screened in the same short period. However, like any weapons of immense power, these techniques must be used with care, to achieve maximum impact. The costs of implementing and running high-throughput screening and combinatorial chemistry are high, as large dedicated facilities must be built and staffed. In addition, the sheer number of chemical leads generated may overwhelm the lead optimisation teams in a hail of friendly fire. Mother nature has not entirely surrendered, as the number of building blocks that could be used to build libraries would require more atoms than there are in the universe. In addition, the progress made by the Human Genome Project has uncovered many proteins with different functions but related binding sites, creating issues of selectivity. Advances in the new field of pharmacogenomics will produce more of these challenges. There is a real need to make hi- throughput screening and combinatorial chemistry into 'smart' weapons, so that their power is not dissipated. That is the challenge for modellers, computational chemists, cheminformaticians and IT experts. In this book, we have broken down this grand challenge into key tasks Chemistry Computer Applications in Chemistry Pharmacy Theoretical and Computational Chemistry Chemoinformatics Chemistry, Physical and theoretical Dean, Philip M. edt Lewis, Richard A. edt Erscheint auch als Druck-Ausgabe 9780792359807 https://doi.org/10.1007/0-306-46873-5 Verlag URL des Erstveröffentlichers Volltext |
spellingShingle | Molecular Diversity in Drug Design Chemistry Computer Applications in Chemistry Pharmacy Theoretical and Computational Chemistry Chemoinformatics Chemistry, Physical and theoretical |
title | Molecular Diversity in Drug Design |
title_auth | Molecular Diversity in Drug Design |
title_exact_search | Molecular Diversity in Drug Design |
title_full | Molecular Diversity in Drug Design edited by Philip M. Dean, Richard A. Lewis |
title_fullStr | Molecular Diversity in Drug Design edited by Philip M. Dean, Richard A. Lewis |
title_full_unstemmed | Molecular Diversity in Drug Design edited by Philip M. Dean, Richard A. Lewis |
title_short | Molecular Diversity in Drug Design |
title_sort | molecular diversity in drug design |
topic | Chemistry Computer Applications in Chemistry Pharmacy Theoretical and Computational Chemistry Chemoinformatics Chemistry, Physical and theoretical |
topic_facet | Chemistry Computer Applications in Chemistry Pharmacy Theoretical and Computational Chemistry Chemoinformatics Chemistry, Physical and theoretical |
url | https://doi.org/10.1007/0-306-46873-5 |
work_keys_str_mv | AT deanphilipm moleculardiversityindrugdesign AT lewisricharda moleculardiversityindrugdesign |